文献速递前列腺癌

早期经会阴模板引导前列腺穿刺活检用于主动监测风险分层的价值

Utility of early transperineal template-guided prostate biopsy for risk stratification in men undergoing active surveillance for prostate cancer.
PubMed 文献 · BJU Int · 2018-01-17

单中心前瞻性研究纳入208例低危或中危前列腺癌患者,在确诊后12个月内行早期mpMRI与经会阴模板引导穿刺活检(TPB)。TPB后39.9%的患者出现病理升级,37.0%的患者治疗方案发生改变;若对PI-RADS评分<3且PSA密度<0.15者省略TPB,12%的更具显著病变患者会被错误分类。

要点

  • 主动监测入组后早期TPB可使39.9%的患者出现Gleason评分升级
  • TPB后37.0%的患者前列腺癌治疗方案发生改变
  • PI-RADS<3且PSA密度<0.15者省略TPB,12%的显著病变会被错误分类

核心结论

  • 主动监测期间行早期TPB与显著病理升级相关,超过三分之一的患者治疗方案发生改变。
  • 若对PI-RADS评分<3且PSA密度<0.15的男性省略TPB,12%的更具显著病变患者会被错误分类。

研究设计与样本

  • 单中心前瞻性研究,2012年4月至2016年12月连续纳入经直肠超声引导活检诊断为低危或中危前列腺癌的男性。
  • 共纳入208例男性,其中196例Gleason评分3+3、12例Gleason评分3+4;入组条件为年龄≤77岁、Gleason评分≤3+4、临床分期T1-T2、PSA≤15 ng/mL、阳性穿刺针数<50%。
  • 入组后12个月内行早期mpMRI与经会阴模板引导前列腺穿刺活检(TPB)。

主要发现

  • TPB中位针数50针(范围17-161),平均TPB针密度1.2针/cm³前列腺体积。
  • 83例(39.9%)TPB后出现组织病理学升级,其中Gleason评分3+3者76例(38.8%)、Gleason评分3+4者7例(58.3%)。
  • 升级病例中26例(31.3%)发现主要成分Gleason分级≥4。
  • 24例(28.9%)升级病例在mpMRI上为PI-RADS评分1或2分病灶,其中包括5例Gleason评分≥4+3者;这24例中14例(58.3%)PSA密度≥0.15,包括5例Gleason≥4+3者中的4例。
  • TPB后共77例(37.0%)前列腺癌治疗方案发生改变。

关键数值与推荐

  • 入组条件:年龄≤77岁;Gleason评分≤3+4;临床分期T1-T2;PSA≤15 ng/mL;阳性穿刺针数<50%。
  • TPB中位针数50针(范围17-161),平均针密度1.2针/cm³前列腺体积。
  • PI-RADS评分<3且PSA密度<0.15者若省略TPB,12%的更具显著病变患者会被错误分类。

临床怎么用

  • 对主动监测入组的低危或中危前列腺癌患者,可在确诊后12个月内行早期mpMRI与TPB以重新评估风险分层。
  • TPB后应根据病理升级情况与PI-RADS评分、PSA密度等结果重新评估治疗方案。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the accuracy and utility of routine multiparametric magnetic resonance imaging (mpMRI) and transperineal template-guided prostate biopsy (TPB) after enrolment in active surveillance (AS). PATIENTS AND METHODS: From April 2012 to December 2016 consecutive men from our single institution, diagnosed with low- or intermediate-risk prostate cancer on transrectal ultrasonography-guided biopsy, were offered further staging with early mpMRI and TPB within 12 months of diagnosis. Data were collected prospectively. Eligibility criteria comprised: age ≤77 years; Gleason score ≤3 + 4; clinical stage T1-T2; PSA ≤15 ng/mL; and <50% positive biopsy cores. RESULTS: A total of 208 men were enrolled, including 196 with Gleason score 3 + 3 and 12 with Gleason score 3 + 4 disease. The median (range) number of TPB cores was 50 (17-161), with a mean TPB core density of 1.2 cores/cm3 prostate volume. A total of 83 men (39.9%) underwent histopathological upgrading after TPB, including 76 men (38.8%) with Gleason score 3 + 3 disease and seven men (58.3%) with Gleason score 3 + 4 disease. Of these, 26 (31.3%) were found to harbour primary pattern Gleason grade ≥4 disease. In all, 24 (28.9%) upgraded cases had Prostate Imaging Reporting and Data System (PI-RADS) score 1 or 2 lesions on mpMRI, including five men with Gleason score ≥4 + 3 disease. Of these, 14 (58.3%) had a prostate-specific antigen (PSA) density of ≥0.15, including four out of the five men with Gleason ≥4 + 3 disease. Overall there was a change in prostate cancer management in 77 men (37.0%) after TPB. CONCLUSIONS: Early TPB during AS is associated with significant upgrading and a change in treatment plan in over a third of men. If TPB was omitted in men with a PI-RADS score <3 and a PSA density <0.15, 12% of those harbouring more significant disease would have been misclassified.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Voss J, Pal R, Ahmed S, et al. Utility of early transperineal template-guided prostate biopsy for risk stratification in men undergoing active surveillance for prostate cancer. BJU Int. 2018. PMID: 29239082. doi:10.1111/bju.14100

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。